Analystreport

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) was given a new $23.71 price target on by analysts at Raymond James.

ACADIA Pharmaceuticals Inc.  (ACAD) 
Last acadia pharmaceuticals inc. earnings: 2/26 04:05 pm Check Earnings Report